R. Kerry Clark Net Worth

The estimated Net Worth of R Kerry Clark is at least $3.59 Million dollars as of 27 October 2023. Mr. Clark owns over 9,353 units of Anthem Inc stock worth over $2,179,814 and over the last 21 years he sold ANTM stock worth over $1,079,060. In addition, he makes $330,481 as Independent Director at Anthem Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Mr. Clark ANTM stock SEC Form 4 insiders trading

R has made over 7 trades of the Anthem Inc stock since 2008, according to the Form 4 filled with the SEC. Most recently he sold 9,353 units of ANTM stock worth $702,410 on 27 October 2023.

The largest trade he's ever made was exercising 17,160 units of Anthem Inc stock on 1 February 2019 worth over $752,123. On average, R trades about 395 units every 29 days since 2003. As of 27 October 2023 he still owns at least 4,517 units of Anthem Inc stock.

You can see the complete history of Mr. Clark stock trades at the bottom of the page.

R. Kerry Clark biography

R. Kerry Clark is Independent Director of Anthem, Inc. Mr. Clark served as Chairman and Chief Executive Officer of Cardinal Health, Inc. (healthcare products and services), until his retirement in 2009. Mr. Clark joined Cardinal Health, Inc. (“Cardinal Health”) in 2006 as President and Chief Executive Officer and became Chairman in 2007. Prior to joining Cardinal Health, he held various positions at The Procter & Gamble Company (consumer products), including President of P&G Asia; President, Global Market Development and Business Operations; and Vice Chairman of the Board, President Global Family Health. He has served as a director of General Mills, Inc. (consumer food products) since 2009 and Textron, Inc. (aircraft, defense, and industrial products) since 2003. He previously served as a director of Avnet, Inc. (industrial distributors of electronic components, enterprise computer and storage products) from 2012 until November 2019. He is also a director of The Christ Hospital in Cincinnati, Ohio (hospital).

What is the salary of R Clark?

As the Independent Director of Anthem Inc, the total compensation of R Clark at Anthem Inc is $330,481. There are 16 executives at Anthem Inc getting paid more, with Gail Boudreaux having the highest compensation of $15,473,100.

How old is R Clark?

R Clark is 67, he's been the Independent Director of Anthem Inc since 2014. There are 4 older and 19 younger executives at Anthem Inc. The oldest executive at Anthem Inc is Julie Hill, 73, who is the Independent Director.

What's R Clark's mailing address?

R's mailing address filed with the SEC is 4101-7S GULF SHORE BLVD N, , NAPLES, FL, 34103.

Insiders trading at Anthem Inc

Over the last 10 years, insiders at Anthem Inc have traded over $153,319,533 worth of Anthem Inc stock and bought 10,600 units worth $3,007,039 . The most active insiders traders include Antonio F Neri, Ryan M. Schneider, and Lewis Iii Hay. On average, Anthem Inc executives and independent directors trade stock every 21 days with the average trade being worth of $5,250,953. The most recent stock trade was executed by Charles Morgan Jr Kendrick on 9 June 2022, trading 6,328 units of ANTM stock currently worth $1,806,771.

What does Anthem Inc do?

Anthem is a leading health benefits company dedicated to improving lives and communities, and making healthcare simpler. Through its affiliated companies, Anthem serves more than 110 million people, including approximately 43 million within its family of health plans. We aim to be the most innovative, valuable and inclusive partner.

Complete history of Mr. Clark stock trades at Anthem Inc, Avnet, Cardinal Health, General Mills, Textron, and Avnet

Anthem Inc executives and stock owners

Anthem Inc executives and other stock owners filed with the SEC include:

• Gail Boudreaux,
  President, Chief Executive Officer, Director
• Felicia Norwood,
  Executive Vice President, President - Government Business Division
• Gloria McCarthy,
  Executive Vice President, Chief Administrative Officer
• Gail Koziara Boudreaux,
  Pres, CEO & Director
• John Gallina,
  Chief Financial Officer, Executive Vice President
• Peter Haytaian,
  Executive Vice President, President of Commercial and Specialty Business Division
• Thomas Zielinski,
  Executive Vice President, General Counsel
• John Edward Gallina,
  Exec. VP & CFO
• Gloria Marie McCarthy,
  Exec. VP and Chief Admin. Officer
• Peter David Haytaian Esq.,
  Exec. VP and Pres of Diversified Bus. & IngenioRx
• Felicia Farr Norwood,
  Exec. VP & Pres of Gov. Bus. Division
• Elizabeth Tallett,
  Independent Chairman of the Board
• Ramiro Peru,
  Independent Director
• Julie Hill,
  Independent Director
• Robert Dixon,
  Independent Director
• Lewis Hay,
  Independent Director
• R. Kerry Clark,
  Independent Director
• Antonio Neri,
  Independent Director
• Bahija Jallal,
  Independent Director
• Ryan Schneider,
  Independent Director
• Chris Rigg,
  Vice President Investor Relations
• Ronald Penczek,
  Senior Vice President, Chief Accounting Officer, Controller
• Prakash Patel,
  Executive Vice President, President - Diversified Business Group
• Leah Stark,
  Chief Human Resource Officer, Executive Vice President
• Stephen Vartan Tanal C.F.A.,
  VP of Investor Relations
• Thomas H. Miller,
  Sr. VP & Chief Information Officer
• Anil Bhatt,
  Chief Technology Officer
• Ronald William Penczek,
  Sr. VP, Controller & Chief Accounting Officer
• Scott Wayne Anglin,
  SVP, Treasurer & Chief Investment Officer
• Joseph Swedish,
  President & CEO
• William J Ryan,
  Director
• George A Jr Schaefer,
  Director
• Jose D. Tomas,
  EVP & Chief HR Officer
• Jacquelyn H Wolf,
  EVP & Chief HR Officer
• Craig E Samitt,
  EVP & Chief Clinical Officer
• Wayne S De Veydt,
  EVP & Chief Financial Officer
• Brian T Griffin,
  EVP & President, CSBD
• Samuel R Md Nussbaum,
  EVP & Chief Medical Officer
• Martin B Silverstein,
  EVP & Chief Strategy Officer
• Kenneth R Goulet,
  EVP, Commercial & Specialty
• Blair Williams Todt,
  EVP and Chief Legal Officer
• Jeffrey D. Alter,
  EVP, IngenioRx & Anthem Health
• Susan D. De Vore,
  Director
• Charles Morgan Jr Kendrick,
  EVP & President, Commercial